Compugen
CGEN
₹148.93
Share price
1.75%
Change (1 day)
-12.16%
Change (1 year)
Categories
Earnings for Compugen (CGEN)
Earnings in 2025 (TTM): -₹0.83 Billion
According to Compugen's latest financial reports the company's current earnings are ₹27.58 Million. In 2024 the company made an earning of -₹0.84 Billion, an increase over its 2023 earnings that were of -₹0.84 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Compugen from 2000 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -₹0.83 Billion | -0.34% |
| 2024 | -₹0.84 Billion | -0.77% |
| 2023 | -₹0.84 Billion | -70.91% |
| 2022 | -₹2.88 Billion | -1.66% |
| 2021 | -₹2.93 Billion | 15.17% |
| 2020 | -₹2.55 Billion | 5.84% |
| 2019 | -₹2.41 Billion | 24.16% |
| 2018 | -₹1.94 Billion | -39.03% |
| 2017 | -₹3.18 Billion | 17.72% |
| 2016 | -₹2.7 Billion | 59.22% |
| 2015 | -₹1.7 Billion | 84.23% |
| 2014 | -₹0.92 Billion | -20.97% |
| 2013 | -₹1.17 Billion | -5.86% |
| 2012 | -₹1.24 Billion | 20.44% |
| 2011 | -₹1.03 Billion | 52.06% |
| 2010 | -₹0.68 Billion | 3.26% |
| 2009 | -₹0.66 Billion | -37.67% |
| 2008 | -₹1.05 Billion | -3.37% |
| 2007 | -₹1.09 Billion | -8.64% |
| 2006 | -₹1.19 Billion | |
| 2004 | -₹1.34 Billion | 9.57% |
| 2003 | -₹1.22 Billion | -5.5% |
| 2002 | -₹1.29 Billion | -20.9% |
| 2001 | -₹1.63 Billion | 27.35% |
| 2000 | -₹1.28 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | -₹67.67 Billion | 8,139.46% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -₹2.97 Billion | 260.92% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | ₹38.85 B | -4,831.63% | 🇮🇱 Israel |
 Genetic Technologies GENE | -₹0.34 Billion | -59.72% | 🇦🇺 Australia |